IsoPlexis to Participate in Upcoming Investor Conferences
November 09 2022 - 6:00AM
IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to
leverage the cells and proteome changing the course of human
health, today announced it will be participating in the following
investor conferences.
- Canaccord Genuity MedTech,
Diagnostics and Digital Health & Services Forum, New York,
NYMulti-Omics Panel on Thursday, November 17th at 1:00 p.m. Eastern
Time / 10:00 a.m. Pacific Time
- Evercore ISI HealthCONx Conference, VirtualFireside Chat on
Thursday, December 1st at 12:10 p.m. Eastern Time / 9:10 a.m.
Pacific Time
A live webcast and replay of the Evercore ISI HealthCONx
Conference fireside chat will be available on the “Investors”
section of the company website at: www.isoplexis.com.
About IsoPlexisIsoPlexis is empowering labs to
leverage the cells and proteome changing the course of human
health. Its platforms provide insights into how multi-functional
immune cells communicate and respond, assisting researchers in
understanding and predicting disease progression, treatment
resistance and therapeutic efficacy.
IsoPlexis has been named Top Innovation or Design by The
Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple
others. The IsoPlexis platform is used globally by researchers,
including those at the top 15 global pharmaceutical companies by
revenue and 78% of leading U.S. comprehensive cancer centers.
Investor Contactinvestors@isoplexis.com
Press Contactpress@isoplexis.com
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Sep 2024 to Oct 2024
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about IsoPlexis Corporation (NASDAQ): 0 recent articles
More News Articles